Susquehanna International Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-150,813
Closed -$264K 7079
2025
Q1
$264K Buy
150,813
+114,625
+317% +$201K ﹤0.01% 5184
2024
Q4
$57.2K Buy
+36,188
New +$57.2K ﹤0.01% 5839
2024
Q3
Hold
0
6387
2024
Q2
Sell
-22,528
Closed -$64.9K 6441
2024
Q1
$64.9K Buy
+22,528
New +$64.9K ﹤0.01% 5119
2023
Q4
Hold
0
6526
2023
Q3
Hold
0
6228
2023
Q2
Hold
0
6336
2023
Q1
Hold
0
6588
2022
Q4
Hold
0
6603
2022
Q3
Hold
0
6774
2022
Q2
Sell
-6,583
Closed -$20K 6534
2022
Q1
$20K Buy
+6,583
New +$20K ﹤0.01% 5470
2021
Q4
Sell
-16,416
Closed -$113K 6347
2021
Q3
$113K Buy
16,416
+3,887
+31% +$26.8K ﹤0.01% 4941
2021
Q2
$102K Buy
+12,529
New +$102K ﹤0.01% 5061
2021
Q1
Hold
0
5666
2020
Q4
Hold
0
5218
2020
Q3
Sell
-6,506
Closed -$44K 4886
2020
Q2
$44K Sell
6,506
-558
-8% -$3.77K ﹤0.01% 4045
2020
Q1
$33K Buy
+7,064
New +$33K ﹤0.01% 4276
2019
Q2
Sell
-1,538
Closed -$16K 4932
2019
Q1
$16K Buy
+1,538
New +$16K ﹤0.01% 2858
2018
Q4
Sell
-2,439
Closed -$58K 4650
2018
Q3
$58K Buy
+2,439
New +$58K ﹤0.01% 3054
2018
Q1
Sell
-272
Closed -$34K 4314
2017
Q4
$34K Buy
+272
New +$34K ﹤0.01% 3487
2017
Q3
Sell
-529
Closed -$63K 4020
2017
Q2
$63K Buy
529
+106
+25% +$12.6K ﹤0.01% 3319
2017
Q1
$83K Sell
423
-225
-35% -$44.1K ﹤0.01% 3003
2016
Q4
$175K Buy
648
+440
+212% +$119K ﹤0.01% 3763
2016
Q3
$82K Buy
208
+117
+129% +$46.1K ﹤0.01% 2727
2016
Q2
$32K Sell
91
-222
-71% -$78.1K ﹤0.01% 3039
2016
Q1
$261K Sell
313
-365
-54% -$304K ﹤0.01% 3116
2015
Q4
$710K Sell
678
-2,508
-79% -$2.63M ﹤0.01% 2671
2015
Q3
$2.5M Buy
3,186
+2,206
+225% +$1.73M ﹤0.01% 1426
2015
Q2
$1.29M Buy
980
+752
+330% +$989K ﹤0.01% 2387
2015
Q1
$463K Buy
228
+36
+19% +$73.1K ﹤0.01% 3162
2014
Q4
$369K Buy
+192
New +$369K ﹤0.01% 3578